Chris Parks

Chris Parks leads IAVI’s Vaccine Design and Development Laboratory in New York where he guides preclinical development of multiple vaccine candidates that are based on vesicular stomatitis virus (VSV) vaccine vector technology.

Parks has worked in vaccine research and development for over 25 years and has been involved in preclinical development and evaluation of vaccine candidates for multiple viral diseases. Before joining IAVI, he led a team of researchers as the senior director of viral vaccines at Wyeth Vaccines, where his team played key roles in preclinical development and evaluation of vaccine candidates against mulitple respiratory viruses and HIV-1, and developed technologies essential to advance recombinant viral vaccines and vaccine vectors for use in people.

Parks received his Ph.D. in microbiology and immunology from the Pennsylvania State University College of Medicine, The Milton S. Hersey Medical Center, and completed postdoctoral training at Princeton University in the Department of Molecular Biology.